Figure 3 | Scientific Reports

Figure 3

From: The “Intermediate” CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans

Figure 3

CD106, CD162 and MPO expression in monocyte subsets.

Surface expression of CD106/VCAM-1 (Panel A) and CD162/PSGL-1 (B) and MPO content (C) were assessed by flow cytometry in each of the three monocyte subsets. Significant increase/decrease of biomarker expression/content are indicated by a p-value < 0.05. Data are presented as box plots, outliers are shown as single dots. Sample sizes are: Rutherford stage I: n = 24, II: n = 8, III: n = 74, IV: n = 16, V: n = 13, VI: n = 8.

Back to article page